Thomson DM, Porter BB, Tall JH, Kim H-J, Barrow JR, Winder WW. Skeletal muscle and heart LKB1 deficiency causes decreased voluntary running and reduced muscle mitochondrial marker enzyme expression in mice. Am J Physiol Endocrinol Metab 292: E196 -E202, 2007. First published August 22, 2006; doi:10.1152/ajpendo.00366.2006.-LKB1 has been identified as a component of the major upstream kinase of AMP-activated protein kinase (AMPK) in skeletal muscle. To investigate the roles of LKB1 in skeletal muscle, we used muscle-specific LKB1 knockout (MLKB1KO) mice that exhibit low expression of LKB1 in heart and skeletal muscle, but not in other tissues. The importance of LKB1 in muscle physiology was demonstrated by the observation that electrical stimulation of the muscle in situ increased AMPK phosphorylation and activity in the wild-type (WT) but not in the muscle-specific LKB1KO mice. Likewise, phosphorylation of acetyl-CoA carboxylase (ACC) was markedly attenuated in the KO mice. The LKB1KO mice had difficulty running on the treadmill and exhibited marked reduction in distance run in voluntary running wheels over a 3-wk period (5.9 Ϯ 0.9 km/day for WT vs. 1.7 Ϯ 0.7 km/day for MLKB1KO mice). The MLKB1KO mice anesthetized at rest exhibited significantly decreased phospho-AMPK and phospho-ACC compared with WT mice. KO mice exhibited lower levels of mitochondrial protein expression in the red and white regions of the quadriceps. These observations, along with previous observations from other laboratories, clearly demonstrate that LKB1 is the major upstream kinase in skeletal muscle and that it is essential for maintaining mitochondrial marker proteins in skeletal muscle. These data provide evidence for a critical role of LKB1 in muscle physiology, one of which is maintaining basal levels of mitochondrial oxidative enzymes. Capacity for voluntary running is compromised with muscle and heart LKB1 deficiency. adenosine 3Ј-cyclic monophosphate-activated protein kinase; muscle specific LKB1 knockout mouse; muscle mitochondria; citrate synthase AMP-ACTIVATED PROTEIN KINASE (AMPK) is a major regulator of skeletal muscle energy metabolism (3,5,27,29). It is activated in response to exercise and muscle contraction and other conditions of metabolic stress when AMP concentration increases (12,19,26,30). When active, AMPK works to restore cellular energy balance by promoting ATP-generating processes such as fatty acid oxidation and glucose uptake, while inhibiting anabolic processes, such as protein synthesis, that consume ATP (3-5, 14, 27-29). In addition to its role in maintaining energy homeostasis during exercise, AMPK is also thought to play an important role in many adaptations to chronic exercise such as elevations in protein levels of GLUT4, hexokinase II, and mitochondrial proteins (2,7,9,25,31,34). AMPK is a heterotrimer composed of a catalytic ␣-subunit and regulatory -and ␥-subunits. Binding of AMP to the ␥-subunit of AMPK promotes phosphorylation at Thr 172 on its ␣-subunit, which is requisite for its activity. Several...
Recent research suggests that LKB1 is the major AMP-activated protein kinase kinase (AMPKK). Peroxisome-proliferator-activated receptor-␥ coactivator-1␣ (PGC-1␣) is a master coordinator of mitochondrial biogenesis. Previously we reported that skeletal muscle LKB1 protein increases with endurance training. The purpose of this study was to determine whether training-induced increases in skeletal muscle LKB1 and PGC-1␣ protein exhibit a time course and intensity-dependent response similar to that of citrate synthase. Male Sprague-Dawley rats completed endurance-and interval-training protocols. For endurance training, rats trained for 4, 11, 25, or 53 days. Interval-training rats trained identically to endurance-trained rats, except that after 25 days interval training was combined with endurance training. Time course data were collected from endurance-trained red quadriceps (RQ) after each time point. Interval training data were collected from soleus, RQ, and white quadriceps (WQ) muscle after 53 days only. Mouse protein 25 (MO25) and PGC-1␣ protein increased significantly after 4 days. Increased citrate synthase activity, increased LKB1 protein, and decreased AMPKK activity were found after 11 days. Maximal increases occurred after 4 days for hexokinase II, 25 days for MO25, and 53 days for citrate synthase, LKB1, and PGC-1␣. In WQ, but not RQ or soleus, interval training had an additive effect to endurance training and induced significant increases in all proteins measured. These results demonstrate that LKB1 and PGC-1␣ protein abundances increase with endurance and interval training similarly to citrate synthase. The increase in LKB1 and PGC-1␣ with endurance and interval training may function to maintain the traininginduced increases in mitochondrial mass. adenosine 5Ј-monophosphate-activated protein kinase, AMP-activated protein kinase kinase; diabetes; MO25, Ste-20-related adaptor protein THE INCIDENCE OF TYPE 2 DIABETES and obesity is increasing at an alarming rate. As of 2002, 8.7% of Americans over age 20 yr and 18.3% of Americans over age 60 yr were diabetic (1). Type 2 diabetes is strongly associated with obesity and is characterized primarily by a reduction in insulin-stimulated glucose uptake. Type 2 diabetes is often accompanied by a decreased skeletal muscle mitochondrial content and a higher-than-normal proportion of type IIx (IIb) muscle fibers (9,24,31,37,48). Regular exercise prevents type 2 diabetes directly by increasing insulin sensitivity and indirectly by decreasing adiposity. Physical activity also increases skeletal muscle mitochondrial mass and induces an increased expression of type IIa myosin heavy chain (MHC) and a decreased expression of type IIx (IIb) MHC (40). Training intensity regulates fiber typespecific training adaptations (2, 57). Higher-intensity training is required for the maximal recruitment and training of type IIx (IIb) fibers (16,46). Hence, interval training might be particularly important for type 2 diabetics.Research during the past decade has characterized some of t...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.